Transcatheter methods of treatment of mitral valve pathology: current state of the problem
Author:
Имаев Т.Э.,Комлев А.Е.,Кучин И.В.,Акчурин Р.С.
Abstract
Во второй части обзора, посвященного транскатетерным методам лечения патологии митрального клапана (МК), рассматриваются вопросы транскатетерного протезирования МК (TMVI), в том числе: имплантация протеза в кальцинированное нативное фиброзное кольцо (valve-in-MAC), в ранее установленные хирургический биопротез (valve-in-valve) и опорное кольцо МК (valve-in-ring). Также кратко обсуждаются сравнительные преимущества и недостатки двух стратегий хирургического лечения - протезирования и пластической реконструкции – в контексте транскатетерной хирургии МК.
Issues of transcatheter mitral valve (MV) implantation (TMVI) including implantation of a prosthesis into calcified native fibrous ring (valve-in-
MAC), into previously implanted surgical bioprosthesis (valve-in-valve) and MV support ring (valve-in-ring) are considered in the second part of the
review devoted to transcatheter methods of treatment of MV pathology. The comparative advantages and disadvantages of two surgical treatment
strategies — prosthetics and plastic reconstruction — are also briefly discussed in the context of MV transcatheter surgery.
Publisher
Media Sphere Publishing Group
Reference15 articles.
1. von Bardeleben RS, Colli A, Schulz E, Ruf T, Wrobel K, Vahl CF, Gerosa G, Werner C, Münzel T, Beiras-Fernandez A. First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and neochord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography fusion imaging. Eur Heart J. 2018; 39:1314-5. https://doi.org/10.1093/eurheartj/ehx595 2. Nagwa Abdelrahman, Mohammed Andaleeb Chowdhury, Arif Al Nooryani, Wael Elabbassi A case of dilated cardiomyopathy and severe mitral regurgitation treated using a combined percutaneous approach of MitraClip followed by CARILLON® mitral contour system Cardiovascular Revascularization Medicine 17 (2016) 578–581 https://doi.org/10.1016/j.carrev.2016.07.001 3. Yoon S-H, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, Eschenbach L, Bansal E, Murdoch DJ, Ancona M, Schmidt T, Yzeiraj E, Vincent F, Niikura H, Kim WK, Asami M, Unbehaun A, Hirji S, Fujita B, Silaschi M, Tang GHL, Kuwata S, Wong SC, Frangieh AH, Barker CM, Davies JE, Lauten A, Deuschl F, Nombela-Franco L, Rampat R, Nicz PFG, Masson JB, Wijeysundera HC, Sievert H, Blackman DJ, Gutierrez-Ibanes E, Sugiyama D, Chakravarty T, Hildick-Smith D, de Brito FS Jr, Jensen C, Jung C, Smalling RW, Arnold M, Redwood S, Kasel AM, Maisano F, Treede H, Ensminger SM, Kar S, Kaneko T, Pilgrim T, Sorajja P, Van Belle E, Prendergast BD, Bapat V, Modine T, Schofer J, Frerker C, Kempfert J, Attizzani GF, Latib A, Schaefer U, Webb JG, Bax JJ, Makkar RR. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J 2019;40(5):441–451. https://doi.org/10.1093/eurheartj/ehy590. 4. Maisano F, Taramasso M. Mitral valve-in-valve, valve-in-ring, and valve-in-MAC: the Good, the Bad, and the Ugly. Eur Heart J. 2019 Feb 1;40(5):452-455. https://doi.org/10.1093/eurheartj/ehy725. 5. Mehaffey HJ, Hawkins RB, Schubert S, Fonner C, Yarboro LT, Quader M, Speir A, Rich J, Kron IL, Ailawadi G. Contemporary outcomes in reoperative mitral valve surgery. Heart 2018;104:652–656. http://dx.doi.org/10.1136/heartjnl-2017-312047
|
|